Sorted By:

Relevance


Many VA Enrollees Supplement Their VA Drug Coverage With Part D or Private Insurance

Chartpack  |  From Our Network

Nearly 7.9 million veterans were enrolled in the VA health care system in 2011; nearly 1.5 million were also enrolled in Medicare Part D, and 2 million had private drug insurance.
http://chartpack.phrma.org/programs-chartpack/medicines-in-veterans-affairs/many-va-enrollees-supplement-their-va-drug-coverage-with-part-d-or-private-insurance

GAO Report Finds Drug Prices Increasing at Lower Rate than Medical Inflation

PhRMA  |  Blog Post

AARP does not take into account generic drugs when making their calculations - even though the generic versions of many medicines found in the AARP report are prescribed nearly 100 percent of the time.
http://catalyst.phrma.org/gao-report-finds-drug-prices-increasing-at-lower-rate-than-medical-inflation

For Cancer Survivors Like Matt, Today is a New Opportunity

From Hope To Cures  |  From Our Network

Learn more about how the biopharmaceutical industry is fighting cancer....
http://www.fromhopetocures.org/video/for-cancer-survivors-like-matt-today-is-a-new-opportunity

World Asthma Day: New Hope for Millions with Asthma

PhRMA  |  Blog Post

In fact, while the rate of diagnosis has increased, through innovative treatments, the number of asthma deaths has decreased by 26 percent since 1999.
http://catalyst.phrma.org/world-asthma-day-new-hope-for-millions-with-asthma

More Than 400 Innovative Medicines in Development For Top Chronic Diseases Affecting Older Americans

PhRMA  |  Press Release

A medicine that recruits a patients’ own neural stem cells to repair or protect against damage to the central nervous system from stress hormones, which can lead to depression.
https://www.phrma.org/press-release/more-than-400-innovative-medicines-in-development-for-top-chronic-diseases-affecting-older-americans

PhRMA Statement on 2016 Special 301 Report

PhRMA  |  Press Release

While biopharmaceutical innovators saw potentially positive signs from the Indian Government in 2015, translating these positive statements into concrete progress has remained a challenge.
https://www.phrma.org/press-release/phrma-statement-on-2016-special-301-report

Consumers Will Pay More Out Of Pocket Next Year For Specialty Drugs

Access Better Coverage  |  From Our Network

  That’s a change from the flat dollar payments of $10 to $30 or $50 that many patients have become accustomed to for other types of drugs.
http://www.accessbettercoverage.org/social-news/consumers-will-pay-more-out-of-pocket-next-year-for-specialty-drugs

Medicare Monday: Why the Independent Payment Advisory Board is Bad For Patients

PhRMA  |  Blog Post


http://catalyst.phrma.org/medicaremonday-why-the-independent-payment-advisory-board-is-bad-for-patients

Labeling Your Health

PhRMA  |  Blog Post

Mit leads PhRMA's law department and is an expert on antitrust and trade regulation, consumer law and life sciences issues.
http://catalyst.phrma.org/labeling-your-health

Examining the brain in The New Era of Medicine

PhRMA  |  Blog Post

Other leaders in the scientific community will discuss the state of research and treatments available, and how the brain processes and perceives information. 
http://catalyst.phrma.org/examining-the-brain-in-the-new-era-of-medicine

Counterfeit Drug Penalty Enhancement Act of 2011 Can Help Crack Down on Counterfeiting Crimes

PhRMA  |  Press Release

Make no mistake: criminals are not only targeting ‘lifestyle’ drugs, but also vital medicines that treat cancer, diabetes, malaria and high blood pressure.
https://www.phrma.org/press-release/counterfeit-drug-penalty-enhancement-act-of-2011-can-help-crack-down-on-counterfeiting-crimes

Don’t lie down!

PhRMA  |  Blog Post

His plan is to become a corporate lawyer, and I am doing everything I can to make that happen for him.
http://catalyst.phrma.org/dont-lay-down

New report highlights impact of intellectual property on U.S. economy

PhRMA  |  Blog Post

A report by NDP Analytics found that between 2000 and 2010, R&D investment in the pharmaceutical manufacturing industry accounted for 27% of all R&D investment among IP-intensive industries.
http://catalyst.phrma.org/new-report-highlights-impact-of-intellectual-property-on-u.s.-economy

Guest Post: The Clinical trial experience from a patient & researcher perspective

PhRMA  |  Blog Post

I have seen the impact of a clinical trial on countless patients I have worked with in my career; I am excited to be able to speak to the other side of the coin as a patient who can one day be a clinical trial participant, too.
http://catalyst.phrma.org/guest-post-the-clinical-trial-experience-from-a-patient-researcher-perspective

U.S. is Still Most Attractive Country for Biopharma Investment; BRICs, Canada Lag Behind

PhRMA  |  Press Release

Nevertheless, in markets that have taken major steps to improve elements of the policy environment – such as Singapore and Israel, which have made significant strides in IP and regulatory standards in recent years – executives display much greater confidence, with these economies averaging at least 75% of the total possible BCI score.”
https://www.phrma.org/press-release/u-s-is-still-most-attractive-country-for-biopharma-investment-brics-canada-lag-behind

Manager – Public Affairs

PhRMA  |  PhRMA Career

Equal Opportunity Employer PhRMA provides equal employment opportunities to all applicants without regard to race, color, religion, national origin, sex, age, marital status, personal appearance, sexual orientation, gender identity or expression, family responsibilities, genetic information, disability, matriculation, political affiliation or veteran status in accordance with applicable federal, state and local laws governing non-discrimination in employment.
https://www.phrma.org

Some Health Insurance Exchange Plans Put All Treatments for Certain Diseases on Top Cost-Sharing Tier

PhRMA  |  Blog Post

This report is evidence that for many, that opportunity has not been realized.
http://catalyst.phrma.org/some-health-insurance-exchange-plans-put-all-treatments-for-certain-diseases-on-top-cost-sharing-tie

Part D

PhRMA  |  From PhRMA

Part D has succeeded beyond expectations, delivering needed prescription medicines at a far lower cost than anticipated due to rigorous competition in the program and accounting for a comparatively small share of total Medicare spending.
https://www.phrma.org/advocacy/medicare/partd

Formulary Restrictions Can Lead to Greater Medical Spending

Chartpack  |  From Our Network

...
http://chartpack.phrma.org/2016-perspective/chapter-4/formulary-restrictions-can-lead-to-greater-medical-spending

More than 50 medicines and vaccines in development for HIV infection, Treatment and Prevention

PhRMA  |  Blog Post

In honor of HIV Testing Day, we are also proud to share the story of one patient through his journey of an HIV positive diagnosis; and his dedication to educating and inspiring others to get tested.
http://catalyst.phrma.org/more-than-50-medicines-and-vaccines-in-development-for-hiv-infection-treatment-and-prevention

New Report: Many Exchange Plans Burden the Most Vulnerable Patients with High Out-of-Pocket Costs for Vital Medicines; Patients left with limited access

PhRMA  |  Press Release

Most carriers use similar formularies across metal tiers and network type within a given state.
https://www.phrma.org/press-release/new-report-many-exchange-plans-burden-the-most-vulnerable-patients-with-high-out-of-pocket-costs-for-vital-medicines-patients-left-with-limited-access

World Cancer Day: Reflecting on progress and hope for the future in cancer treatment

PhRMA  |  Blog Post

As we reflect on World Cancer Day, we are energized by the progress we have made against cancer and have tremendous hope for the future.
http://catalyst.phrma.org/world-cancer-day-reflecting-on-progress-and-hope-for-the-future-in-cancer-treatment

Guest Post: Room for optimism in ALS research

PhRMA  |  Blog Post

There are so many different ways that everyone can show their support for the battle against rare disease and I would encourage them to do so.
http://catalyst.phrma.org/guest-post-room-for-optimism-in-als-research

Week in Review: The Latest from PhRMA

PhRMA  |  Blog Post


http://catalyst.phrma.org/week-in-review-the-latest-from-phrma-may-29-2015

New Report: Past Drug Failures Help Create the War on Cancer’s Next Successes

PhRMA  |  Press Release

Research has shown that cancer is actually a set of more than 200 extremely complex diseases and discovering medicines that effectively treat each one is a difficult task.
https://www.phrma.org/press-release/new-report-past-drug-failures-help-create-the-war-on-cancer-s-next-successes

You have reviewed the first 275 results out of 2151. Each page contains 25 results. You're on page 11.

prev 7 8 9 10 11 12 next